| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |